We're on the Move! Starting from May 28th, 2024, you will find all the details of our Recombumin® portfolio and Albumedix' services at our new online home, sartorius.com
Albumedix Partnering

Dedicated to better health we partner with excellence to improve therapies for people with serious diseases by continuing to explore the vast possibilities of albumin and the continued support of albumin science.

In Albumedix we are always seeking partners and collaborators to unlock the full potential of albumin. Among others this include likeminded technology developers, academic institutions as well as drug and medical device developers. Together we aspire to pioneer innovations within the field of albumin enabled therapeutics through the commitment to Better Health.   

 

"We value long standing relationships and believe in an outside-in approach to our innovation and business "

- Peter Rosholm, Member of Board of Directors of Albumedix

 

Enquire about Recombumin® today

CONTACT

Albumedix Ltd.
Mabel Street
The Meadows
Nottingham
NG2 3ED, United Kingdom
Tel: +44 115 9553379
info@albumedix.com

 

Albumedix - Dedicated to Better Health

Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with ~100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.

 

Privacy | Cookies | Patent Portfolio

ALBUMEDIX, the ALBUMEDIX LOGO, DEDICATED TO BETTER HEALTH and marks such as RECOMBUMIN and VELTIS are trademarks of Albumedix. Albumedix© Copyright 2018

FOLLOW US